Bio News

Cellid will raise 10 billion won by issuing 4,796,163 common shares through a third-party allotment.
The new shares will be issued at 2,085 won per share, a 10% discount to the reference price of 2,316 won.
Upon completion of payment, Huniverse Global is expected to become the largest shareholder.

BIOBOOK TEAM
biobookmedia@biobook.co.krEuropean CHMP Recommends Approval of AstraZeneca’s Blood Pressure Drug Baxpendi
Novo Seeks U.S. and European Approval for Sickle Cell Drug Etavopivat
Rezolute Meets Primary Endpoint in Phase 3 Trial for Tumor Hyperinsulinism; FDA Meeting Ahead
Five Brain Disease Startups Raise $450 Million in a Few Weeks
American Cancer Society Revises Prostate Cancer Screening Guidelines for First Time in 16 Years
Shin Dong-kook Raises Stake in Hanmi Science to 30.18% With Over-the-Counter Purchase of 1.38 Million Shares